Experimental evidence demonstrated age-associated NHP2 overexpression in CRC pathological specimens, while subsequent in vitro and in vivo models confirmed its pivotal role in tumor progression through telomere homeostasis modulation, thereby mediating critical oncogenic biological processes (Gong et al., 2021). This evidence concerns the gene NHP2 and neoplasm.